Consolidated Statements of Cash Flow - USD ($)	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss including non controlling interest	$ (35,188,253)	$ (10,086,470)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	780,853	772,259
Stock based compensation	3,526,209
Deferred income taxes	79,094	(89,509)
Unrealised foreign exchange loss/(profit)	(28,884)	(4,672)
Fair value losses in financial instruments carried at fair value	23,590,000	5,026,894
Expected credit loss allowance	171,946
Lease equalisation reserve	0	(9,715)
Balances written off/(back)	(1,609)	0
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:
Inventories	(73,732)	(9,149)
Income taxes, net	19,297	(47,545)
Accounts receivables, net	4,352,472	169,205
Prepayments and other assets	(30,343,651)	(627,470)
Accounts payable and accrued expenses and other current liabilities	19,106,908	(163,364)
Other liabilities	(1,118,459)	412,803
Net cash used in operating activities	(15,127,809)	(4,656,733)
Cash flows from investing activities
Purchase of property and equipment, intangible assets and goodwill	(136,220)	(711,706)
Acquisition of business	(5,748,000)	0
Net cash used in investing activities	(5,884,220)	(711,706)
Cash flows from financing activities:
Proceeds from business combination	32,770
Proceeds from issue of preferred stock	6,079,409	0
Proceeds from long-term borrowings	2,805,418	2,164,728
Repayments of long-term borrowings	(569,207)	(243,406)
Net proceeds/(payments) from short-term borrowings	9,218,689	3,700,604
Net cash generated from financing activities	17,567,079	5,621,926
Effect of exchange rate changes on cash and cash equivalents	56,372	(26,055)
Net (decrease)/increase in cash and cash equivalents (including restricted cash)	(3,388,578)	227,432
Cash acquired in business combination	11,252,547	0
Cash and cash equivalents at the beginning of the period (including restricted cash)	1,131,830	1,086,418
Cash and cash equivalents at the end of the period (including restricted cash)	8,995,799	1,313,850
Reconciliation of cash and cash equivalents
Cash and cash equivalents	8,109,694	1,153,240
Restricted cash	886,105	160,610
Total cash and cash equivalents	8,995,799	1,313,850
Supplemental Cash Flow Information [Abstract]
Cash paid for interest, net of amounts capitalized	378,064	145,061
Cash paid for income taxes, net of refunds	83,680	133,875
Non-cash investing and financing activities
Convertible preferred stock issued on conversion of convertible notes	0	10,141,462
Consideration payable in connection with acquisitions	1,854,732	611,204
Interest accrued on borrowings	$ 157,649	$ 0